☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Jersey, Channel Islands | 98-1499339 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Ordinary Shares of 10 pence | FERG | New York Stock Exchange | ||||||
London Stock Exchange |
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
PAGE |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions, except per share amounts) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales | $6,673 | $6,825 | $14,381 | $14,756 | |||||||||||||||||||
Cost of sales | (4,644) | (4,763) | (10,021) | (10,273) | |||||||||||||||||||
Gross profit | 2,029 | 2,062 | 4,360 | 4,483 | |||||||||||||||||||
Selling, general and administrative expenses | (1,469) | (1,432) | (2,981) | (2,941) | |||||||||||||||||||
Depreciation and amortization | (83) | (81) | (163) | (162) | |||||||||||||||||||
Operating profit | 477 | 549 | 1,216 | 1,380 | |||||||||||||||||||
Interest expense, net | (44) | (47) | (89) | (88) | |||||||||||||||||||
Other expense, net | — | (7) | (3) | (5) | |||||||||||||||||||
Income before income taxes | 433 | 495 | 1,124 | 1,287 | |||||||||||||||||||
Provision for income taxes | (111) | (121) | (283) | (318) | |||||||||||||||||||
Net income | $322 | $374 | $841 | $969 | |||||||||||||||||||
Earnings per share - Basic | $1.58 | $1.81 | $4.13 | $4.66 | |||||||||||||||||||
Earnings per share - Diluted | $1.58 | $1.80 | $4.12 | $4.64 | |||||||||||||||||||
Weighted average number of shares outstanding: | |||||||||||||||||||||||
Basic | 203.4 | 207.1 | 203.6 | 207.9 | |||||||||||||||||||
Diluted | 203.9 | 207.8 | 204.2 | 208.8 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net income | $322 | $374 | $841 | $969 | |||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Foreign currency translation adjustments | 21 | 18 | (14) | (18) | |||||||||||||||||||
Pension adjustments, net of tax expense of ($2) ($3), ($2) and ($1), respectively. | 4 | 8 | 5 | 7 | |||||||||||||||||||
Total other comprehensive income (loss), net of tax | 25 | 26 | (9) | (11) | |||||||||||||||||||
Comprehensive income | $347 | $400 | $832 | $958 |
As of | |||||||||||
(In millions, except share amounts) | January 31, 2024 | July 31, 2023 | |||||||||
Assets | |||||||||||
Cash and cash equivalents | $639 | $601 | |||||||||
Accounts receivable, less allowances of $37 and $27, respectively | 3,092 | 3,597 | |||||||||
Inventories | 3,968 | 3,898 | |||||||||
Prepaid and other current assets | 891 | 953 | |||||||||
Assets held for sale | 26 | 28 | |||||||||
Total current assets | 8,616 | 9,077 | |||||||||
Property, plant and equipment, net | 1,675 | 1,595 | |||||||||
Operating lease right-of-use assets | 1,523 | 1,474 | |||||||||
Deferred income taxes, net | 300 | 300 | |||||||||
Goodwill | 2,264 | 2,241 | |||||||||
Other intangible assets, net | 755 | 783 | |||||||||
Other non-current assets | 554 | 524 | |||||||||
Total assets | $15,687 | $15,994 | |||||||||
Liabilities and shareholders’ equity | |||||||||||
Accounts payable | $2,985 | $3,408 | |||||||||
Short-term debt | 150 | 55 | |||||||||
Current portion of operating lease liabilities | 379 | 366 | |||||||||
Other current liabilities | 1,274 | 1,600 | |||||||||
Total current liabilities | 4,788 | 5,429 | |||||||||
Long-term debt | 3,595 | 3,711 | |||||||||
Long-term portion of operating lease liabilities | 1,165 | 1,126 | |||||||||
Other long-term liabilities | 721 | 691 | |||||||||
Total liabilities | 10,269 | 10,957 | |||||||||
Shareholders’ equity: | |||||||||||
Ordinary shares, par value 10 pence: 500,000,000 shares authorized, 232,171,182 shares issued | 30 | 30 | |||||||||
Paid-in capital | 842 | 809 | |||||||||
Retained earnings | 9,018 | 8,557 | |||||||||
Treasury shares, 29,168,420 and 27,893,680 shares, respectively at cost | (3,575) | (3,425) | |||||||||
Employee Benefit Trusts, 0 and 274,031 shares, respectively at cost | — | (46) | |||||||||
Accumulated other comprehensive loss | (897) | (888) | |||||||||
Total shareholders' equity | 5,418 | 5,037 | |||||||||
Total liabilities and shareholders' equity | $15,687 | $15,994 |
Three Months Ended January 31, 2024 | |||||||||||||||||||||||
(In millions, except per share data) | Ordinary Shares | Paid-in Capital | Retained Earnings | Treasury Shares | Employee Benefit Trusts | Accumulated Other Comprehensive Loss | Total Shareholders’ Equity | ||||||||||||||||
Balance at October 31, 2023 | $30 | $828 | $8,858 | ($3,433) | ($1) | ($922) | $5,360 | ||||||||||||||||
Share-based compensation | — | 12 | — | — | — | — | 12 | ||||||||||||||||
Net income | — | — | 322 | — | — | — | 322 | ||||||||||||||||
Cash dividends declared ($0.79) per share | — | — | (160) | — | — | — | (160) | ||||||||||||||||
Other comprehensive income | — | — | — | — | — | 25 | 25 | ||||||||||||||||
Share repurchases | — | — | — | (143) | — | — | (143) | ||||||||||||||||
Shares issued under employee share plans | — | — | (2) | 1 | — | — | (1) | ||||||||||||||||
Other | 2 | — | 1 | 3 | |||||||||||||||||||
Balance at January 31, 2024 | $30 | $842 | $9,018 | ($3,575) | $— | ($897) | $5,418 |
Six months ended January 31, 2024 | |||||||||||||||||||||||
(In millions, except per share data) | Ordinary Shares | Paid-in Capital | Retained Earnings | Treasury Shares | Employee Benefit Trusts | Accumulated Other Comprehensive Loss | Total Shareholders’ Equity | ||||||||||||||||
Balance at July 31, 2023 | $30 | $809 | $8,557 | ($3,425) | ($46) | ($888) | $5,037 | ||||||||||||||||
Share-based compensation | — | 31 | — | — | — | — | 31 | ||||||||||||||||
Net income | — | — | 841 | — | — | — | 841 | ||||||||||||||||
Cash dividends declared ($1.54) per share | — | — | (312) | — | — | — | (312) | ||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (9) | (9) | ||||||||||||||||
Share repurchases | — | — | — | (176) | — | — | (176) | ||||||||||||||||
Shares issued under employee share plans | — | — | (68) | 26 | 45 | — | 3 | ||||||||||||||||
Other | — | 2 | — | — | 1 | — | 3 | ||||||||||||||||
Balance at January 31, 2024 | $30 | $842 | $9,018 | ($3,575) | $— | ($897) | $5,418 |
Three Months Ended January 31, 2023 | |||||||||||||||||||||||
(In millions, except per share data) | Ordinary Shares | Paid-in Capital | Retained Earnings | Treasury Shares | Employee Benefit Trusts | Accumulated Other Comprehensive Loss | Total Shareholders’ Equity | ||||||||||||||||
Balance at October 31, 2022 | $30 | $773 | $8,129 | ($2,897) | ($47) | ($867) | $5,121 | ||||||||||||||||
Share-based compensation | — | 16 | — | — | — | — | 16 | ||||||||||||||||
Net income | — | — | 374 | — | — | — | 374 | ||||||||||||||||
Other comprehensive income | — | — | — | — | — | 26 | 26 | ||||||||||||||||
Cash dividends declared ($2.66) per share | — | — | (552) | — | — | — | (552) | ||||||||||||||||
Share repurchases | — | — | — | (260) | — | — | (260) | ||||||||||||||||
Shares issued under employee share plans | — | — | (6) | 6 | — | — | — | ||||||||||||||||
Balance at January 31, 2023 | $30 | $789 | $7,945 | ($3,151) | ($47) | ($841) | $4,725 |
Six months ended January 31, 2023 | |||||||||||||||||||||||
(In millions, except per share data) | Ordinary Shares | Paid-in Capital | Retained Earnings | Treasury Shares | Employee Benefit Trusts | Accumulated Other Comprehensive Loss | Total Shareholders’ Equity | ||||||||||||||||
Balance at July 31, 2022 | $30 | $760 | $7,594 | ($2,782) | ($107) | ($830) | $4,665 | ||||||||||||||||
Share-based compensation | — | 29 | — | — | — | — | 29 | ||||||||||||||||
Net income | — | — | 969 | — | — | — | 969 | ||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (11) | (11) | ||||||||||||||||
Cash dividends declared ($2.66) per share | — | — | (552) | — | — | — | (552) | ||||||||||||||||
Share repurchases | — | — | — | (375) | — | — | (375) | ||||||||||||||||
Shares issued under employee share plans | — | — | (66) | 6 | 60 | — | — | ||||||||||||||||
Balance at January 31, 2023 | $30 | $789 | $7,945 | ($3,151) | ($47) | ($841) | $4,725 |
(In millions) | Six months ended | ||||||||||
January 31, | |||||||||||
2024 | 2023 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $841 | $969 | |||||||||
Depreciation and amortization | 163 | 162 | |||||||||
Share-based compensation | 24 | 27 | |||||||||
Change in deferred income taxes | (6) | (38) | |||||||||
(Increase) decrease in inventories | (52) | 237 | |||||||||
Decrease in receivables and other assets | 565 | 512 | |||||||||
Decrease in accounts payable and other liabilities | (626) | (634) | |||||||||
Decrease in income taxes payable | (40) | (63) | |||||||||
Other operating activities | (6) | 3 | |||||||||
Net cash provided by operating activities of continuing operations | 863 | 1,175 | |||||||||
Net cash used in operating activities of discontinued operations | — | (4) | |||||||||
Net cash provided by operating activities | 863 | 1,171 | |||||||||
Cash flows from investing activities: | |||||||||||
Purchase of businesses acquired, net of cash acquired | (67) | (179) | |||||||||
Capital expenditures | (192) | (242) | |||||||||
Other investing activities | 28 | (4) | |||||||||
Net cash used in investing activities | (231) | (425) | |||||||||
Cash flows from financing activities: | |||||||||||
Purchase of treasury shares | (250) | (564) | |||||||||
Repayments of debt | (1,155) | (1,880) | |||||||||
Proceeds from debt | 1,125 | 1,950 | |||||||||
Change in bank overdrafts | 6 | 4 | |||||||||
Cash dividends | (305) | (403) | |||||||||
Other financing activities | (18) | (13) | |||||||||
Net cash used in financing activities | (597) | (906) | |||||||||
Change in cash, cash equivalents and restricted cash | 35 | (160) | |||||||||
Effects of exchange rate changes | — | 19 | |||||||||
Cash, cash equivalents and restricted cash, beginning of period | 669 | 785 | |||||||||
Cash, cash equivalents and restricted cash, end of period | $704 | $644 | |||||||||
Supplemental Disclosures: | |||||||||||
Cash paid for income taxes | $330 | $419 | |||||||||
Cash paid for interest | 97 | 83 | |||||||||
Accrued capital expenditures | 6 | 7 | |||||||||
Accrued dividends | 161 | 156 |
As of | |||||||||||
(In millions) | January 31, 2024 | July 31, 2023 | |||||||||
Cash and cash equivalents | $639 | $601 | |||||||||
Restricted cash | 65 | 68 | |||||||||
Total cash, cash equivalents and restricted cash | $704 | $669 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales: | |||||||||||||||||||||||
United States | $6,364 | $6,504 | $13,693 | $14,036 | |||||||||||||||||||
Canada | 309 | 321 | 688 | 720 | |||||||||||||||||||
Total net sales | $6,673 | $6,825 | $14,381 | $14,756 | |||||||||||||||||||
Adjusted operating profit: | |||||||||||||||||||||||
United States | $525 | $579 | $1,291 | $1,424 | |||||||||||||||||||
Canada | 9 | 14 | 32 | 47 | |||||||||||||||||||
Central and other costs | (14) | (11) | (30) | (25) | |||||||||||||||||||
Corporate restructurings(1) | (8) | — | (8) | — | |||||||||||||||||||
Amortization of acquired intangible assets | (35) | (33) | (69) | (66) | |||||||||||||||||||
Interest expense, net | (44) | (47) | (89) | (88) | |||||||||||||||||||
Other expense, net | — | (7) | (3) | (5) | |||||||||||||||||||
Income before income taxes | $433 | $495 | $1,124 | $1,287 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
United States: | |||||||||||||||||||||||
Residential | $3,299 | $3,420 | $7,039 | $7,422 | |||||||||||||||||||
Non-residential: | |||||||||||||||||||||||
Commercial | 2,122 | 2,114 | 4,592 | 4,533 | |||||||||||||||||||
Civil/Infrastructure | 508 | 508 | 1,141 | 1,146 | |||||||||||||||||||
Industrial | 435 | 462 | 921 | 935 | |||||||||||||||||||
Total Non-residential | 3,065 | 3,084 | 6,654 | 6,614 | |||||||||||||||||||
Total United States | 6,364 | 6,504 | 13,693 | 14,036 | |||||||||||||||||||
Canada | 309 | 321 | 688 | 720 | |||||||||||||||||||
Total net sales | $6,673 | $6,825 | $14,381 | $14,756 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Basic weighted average shares | 203.4 | 207.1 | 203.6 | 207.9 | |||||||||||||||||||
Effect of dilutive shares(1) | 0.5 | 0.7 | 0.6 | 0.9 | |||||||||||||||||||
Diluted weighted average shares | 203.9 | 207.8 | 204.2 | 208.8 | |||||||||||||||||||
Excluded anti-dilutive shares | — | 0.1 | 0.1 | 0.1 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Effective tax rate, continuing operations | 25.6 | % | 24.4 | % | 25.2 | % | 24.7 | % |
As of | |||||||||||
(In millions) | January 31, 2024 | July 31, 2023 | |||||||||
Variable-rate debt: | |||||||||||
Receivables Facility | $75 | $50 | |||||||||
Term Loan | 500 | 500 | |||||||||
Fixed-rate debt: | |||||||||||
Private placement notes | 850 | 905 | |||||||||
Unsecured senior notes | 2,350 | 2,350 | |||||||||
Subtotal | $3,775 | $3,805 | |||||||||
Less: current maturities of debt | (150) | (55) | |||||||||
Unamortized discounts and debt issuance costs | (19) | (22) | |||||||||
Interest rate swap - fair value adjustment | (11) | (17) | |||||||||
Total long-term debt | $3,595 | $3,711 |
January 31, 2024 | July 31, 2023 | ||||||||||||||||||||||
(In millions) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||||||||||
Unsecured senior notes | $2,332 | $2,269 | $2,330 | $2,195 | |||||||||||||||||||
Private placement notes | 849 | 832 | 904 | 871 |
(In millions, net of tax) | Foreign currency translation | Pensions | Total | ||||||||||||||
Balance at July 31, 2023 | ($429) | ($459) | ($888) | ||||||||||||||
Other comprehensive loss before reclassifications | (35) | (2) | (37) | ||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 3 | 3 | ||||||||||||||
Other comprehensive (loss) income | (35) | 1 | (34) | ||||||||||||||
Balance at October 31, 2023 | (464) | (458) | (922) | ||||||||||||||
Other comprehensive income before reclassifications | 21 | 2 | 23 | ||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 2 | 2 | ||||||||||||||
Other comprehensive income | 21 | 4 | 25 | ||||||||||||||
Balance at January 31, 2024 | ($443) | ($454) | ($897) | ||||||||||||||
(In millions, net of tax) | Foreign currency translation | Pensions | Total | ||||||||||||||
Balance at July 31, 2022 | ($420) | ($410) | ($830) | ||||||||||||||
Other comprehensive loss before reclassifications | (36) | (3) | (39) | ||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 2 | 2 | ||||||||||||||
Other comprehensive loss | (36) | (1) | (37) | ||||||||||||||
Balance at October 31, 2022 | (456) | (411) | (867) | ||||||||||||||
Other comprehensive income before reclassifications | 18 | 6 | 24 | ||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 2 | 2 | ||||||||||||||
Other comprehensive income | 18 | 8 | 26 | ||||||||||||||
Balance at January 31, 2023 | ($438) | ($403) | ($841) | ||||||||||||||
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Amortization of actuarial losses | $3 | $3 | $7 | $6 | |||||||||||||||||||
Tax benefit | (1) | (1) | (2) | (2) | |||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | $2 | $2 | $5 | $4 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Interest cost | ($15) | ($13) | ($30) | ($25) | |||||||||||||||||||
Expected return on plan assets | 15 | 12 | 30 | 24 | |||||||||||||||||||
Amortization of net actuarial losses | (3) | (3) | (7) | (6) | |||||||||||||||||||
Net periodic cost | ($3) | ($4) | ($7) | ($7) |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Ordinary shares: | |||||||||||||||||||||||
Balance at beginning of period | 232,171,182 | 232,171,182 | 232,171,182 | 232,171,182 | |||||||||||||||||||
Change in shares issued | — | — | — | — | |||||||||||||||||||
Balance at end of period | 232,171,182 | 232,171,182 | 232,171,182 | 232,171,182 | |||||||||||||||||||
Treasury shares: | |||||||||||||||||||||||
Balance at beginning of period | (28,382,963) | (24,069,674) | (27,893,680) | (21,078,577) | |||||||||||||||||||
Repurchases of ordinary shares | (794,755) | (1,601,423) | (1,492,153) | (4,592,520) | |||||||||||||||||||
Treasury shares used to settle share-based compensation awards | 9,298 | 51,162 | 217,413 | 51,162 | |||||||||||||||||||
Balance at end of period | (29,168,420) | (25,619,935) | (29,168,420) | (25,619,935) | |||||||||||||||||||
Employee Benefit Trusts: | |||||||||||||||||||||||
Balance at beginning of period | (20,819) | (284,562) | (274,031) | (846,491) | |||||||||||||||||||
Employee Benefit Trust shares used to settle share-based compensation awards | — | 958 | 253,212 | 562,887 | |||||||||||||||||||
Shares sold upon termination of Employee Benefit Trust | 20,819 | — | 20,819 | — | |||||||||||||||||||
Balance at end of period | — | (283,604) | — | (283,604) | |||||||||||||||||||
Total shares outstanding at end of period | 203,002,762 | 206,267,643 | 203,002,762 | 206,267,643 |
Number of shares | Weighted average grant date fair value | ||||||||||
Outstanding at July 31, 2023 | 1,158,673 | $111.57 | |||||||||
Time vested awards | 111,285 | 160.64 | |||||||||
Performance vested awards | 209,280 | 158.10 | |||||||||
LTI-ED, equity-settled awards | 32,050 | 149.37 | |||||||||
Share adjustments based on performance | (23,413) | 41.67 | |||||||||
Vested | (469,978) | 98.79 | |||||||||
Forfeited | (14,515) | 121.33 | |||||||||
Outstanding at January 31, 2024 | 1,003,382 | $135.40 |
Six months ended | |||||
January 31, | |||||
(In millions, except per share amounts) | 2024 | ||||
Fair value of awards vested | $77 | ||||
Weighted average grant date fair value per share granted | $158.11 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Share-based compensation expense (within SG&A) | $11 | $15 | $24 | $27 | |||||||||||||||||||
Income tax benefit | 3 | 4 | 6 | 7 |
Six months ended | |||||
(In millions) | January 31, 2024 | ||||
Purchase consideration | $68 | ||||
Cash, cash equivalents and bank overdrafts acquired | (1) | ||||
Cash consideration paid, net of cash acquired | 67 | ||||
Deferred and contingent consideration(1) | 20 | ||||
Net cash outflow in respect of the purchase of businesses | $87 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Pro forma net sales | $6,700 | $6,858 | $14,442 | $14,822 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions, except per share amounts) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales | $6,673 | $6,825 | $14,381 | $14,756 | |||||||||||||||||||
Operating profit | 477 | 549 | 1,216 | 1,380 | |||||||||||||||||||
Net income | 322 | 374 | 841 | 969 | |||||||||||||||||||
Earnings per share - diluted | 1.58 | 1.80 | 4.12 | 4.64 | |||||||||||||||||||
Net cash provided by operating activities | 863 | 1,171 | |||||||||||||||||||||
Supplemental non-GAAP financial measures:(1) | |||||||||||||||||||||||
Adjusted operating profit | 520 | 582 | 1,293 | 1,446 | |||||||||||||||||||
Adjusted earnings per share - diluted | 1.74 | 1.91 | 4.40 | 4.87 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales | $6,673 | $6,825 | $14,381 | $14,756 | |||||||||||||||||||
Cost of sales | (4,644) | (4,763) | (10,021) | (10,273) | |||||||||||||||||||
Gross profit | 2,029 | 2,062 | 4,360 | 4,483 | |||||||||||||||||||
Selling, general and administrative expenses | (1,469) | (1,432) | (2,981) | (2,941) | |||||||||||||||||||
Depreciation and amortization | (83) | (81) | (163) | (162) | |||||||||||||||||||
Operating profit | 477 | 549 | 1,216 | 1,380 | |||||||||||||||||||
Interest expense, net | (44) | (47) | (89) | (88) | |||||||||||||||||||
Other expense, net | — | (7) | (3) | (5) | |||||||||||||||||||
Income before income taxes | 433 | 495 | 1,124 | 1,287 | |||||||||||||||||||
Provision for income taxes | (111) | (121) | (283) | (318) | |||||||||||||||||||
Net income | $322 | $374 | $841 | $969 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales | $6,364 | $6,504 | $13,693 | $14,036 | |||||||||||||||||||
Adjusted operating profit | 525 | 579 | 1,291 | 1,424 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net sales | $309 | $321 | $688 | $720 | |||||||||||||||||||
Adjusted operating profit | 9 | 14 | 32 | 47 |
Three months ended | Six months ended | ||||||||||||||||||||||
January 31, | January 31, | ||||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net income | $322 | $374 | $841 | $969 | |||||||||||||||||||
Provision for income taxes | 111 | 121 | 283 | 318 | |||||||||||||||||||
Interest expense, net | 44 | 47 | 89 | 88 | |||||||||||||||||||
Other expense (income), net | — | 7 | 3 | 5 | |||||||||||||||||||
Operating profit | 477 | 549 | 1,216 | 1,380 | |||||||||||||||||||
Corporate restructurings(1) | 8 | — | 8 | — | |||||||||||||||||||
Amortization of acquired intangibles | 35 | 33 | 69 | 66 | |||||||||||||||||||
Adjusted operating profit | $520 | $582 | $1,293 | $1,446 |
Three months ended | |||||||||||||||||||||||
January 31, | |||||||||||||||||||||||
(In millions, except per share amounts) | 2024 | 2023 | |||||||||||||||||||||
per share(1) | per share(1) | ||||||||||||||||||||||
Net income | $322 | $1.58 | $374 | $1.80 | |||||||||||||||||||
Corporate restructurings(2) | 8 | 0.04 | — | — | |||||||||||||||||||
Amortization of acquired intangibles | 35 | 0.17 | 33 | 0.16 | |||||||||||||||||||
Discrete tax adjustments(3) | (2) | (0.01) | (3) | (0.01) | |||||||||||||||||||
Tax impact on non-GAAP adjustments(4) | (8) | (0.04) | (8) | (0.04) | |||||||||||||||||||
Adjusted net income | $355 | $1.74 | $396 | $1.91 | |||||||||||||||||||
Diluted weighted average shares outstanding | 203.9 | 207.8 |
Six months ended | |||||||||||||||||||||||
January 31, | |||||||||||||||||||||||
(In millions, except per share amounts) | 2024 | 2023 | |||||||||||||||||||||
per share(1) | per share(1) | ||||||||||||||||||||||
Net income | $841 | $4.12 | $969 | $4.64 | |||||||||||||||||||
Corporate restructurings(2) | 8 | 0.04 | — | — | |||||||||||||||||||
Amortization of acquired intangibles | 69 | 0.34 | 66 | 0.32 | |||||||||||||||||||
Discrete tax adjustments(3) | (2) | (0.01) | (3) | (0.01) | |||||||||||||||||||
Tax impact on non-GAAP adjustments(4) | (18) | (0.09) | (16) | (0.08) | |||||||||||||||||||
Adjusted net income | $898 | $4.40 | $1,016 | $4.87 | |||||||||||||||||||
Diluted weighted average shares | 204.2 | 208.8 |
Six months ended | |||||||||||
January 31, | |||||||||||
(In millions) | 2024 | 2023 | |||||||||
Net cash provided by operating activities | $863 | $1,171 |
Six months ended | |||||||||||
January 31, | |||||||||||
(In millions) | 2024 | 2023 | |||||||||
Net cash used in investing activities | ($231) | ($425) |
Six months ended | |||||||||||
January 31, | |||||||||||
(In millions) | 2024 | 2023 | |||||||||
Net cash used in financing activities | ($597) | ($906) |
As of | |||||||||||
(In millions) | January 31, 2024 | July 31, 2023 | |||||||||
Short-term debt | $150 | $55 | |||||||||
Long-term debt | 3,595 | 3,711 | |||||||||
Total debt | $3,745 | $3,766 |
(In millions, except share count and per share amount) | (a) Total Number of Shares Purchased | (b) Average Prices Paid per Share | (c) Total Number of Shares Purchased as Part of Publicly Announced Program(1) | (d) Maximum Value of Shares that May Yet Be Purchased Under the Program(1) | ||||||||||||||||||||||
November 1 - November 30, 2023 | 298,568 | $162.78 | 298,568 | $380 | ||||||||||||||||||||||
December 1 - December 31, 2023 | 191,260 | $194.06 | 191,260 | $343 | ||||||||||||||||||||||
January 1 - January 31, 2024 | 304,927 | $189.24 | 304,927 | $285 | ||||||||||||||||||||||
794,755 | 794,755 |
(a) | Exhibits |
Exhibit | Description | |||||||
2.1 | ||||||||
3.1 | ||||||||
10.1 | ||||||||
10.2 | ||||||||
10.3 | ||||||||
31.1* | ||||||||
31.2* | ||||||||
32.1** | ||||||||
32.2** | ||||||||
101.INS* | Inline XBRL Instance Document—this instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document | |||||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |||||||
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Ferguson plc | ||||||||
/s/ William Brundage | ||||||||
Name: | William Brundage | |||||||
Title: | Chief Financial Officer | |||||||
(Principal Financial Officer and Duly Authorized Officer) |
Date: March 6, 2024 | /s/ Kevin Murphy | |||||||
Name: | Kevin Murphy | |||||||
Title: | Chief Executive Officer |
Date: March 6, 2024 | /s/ William Brundage | |||||||
Name: | William Brundage | |||||||
Title: | Chief Financial Officer |
/s/ Kevin Murphy | ||||||||
Name: | Kevin Murphy | |||||||
Title: | Chief Executive Officer |
/s/ William Brundage | ||||||||
Name: | William Brundage | |||||||
Title: | Chief Financial Officer |